Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology Deal

Merck gets Canadian nod for Keytruda in combo with fluoropyrimidine- and platinum-containing-chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma

Ruchika Sharma23 April 2024 3:08 PM IST

Kirkland: Merck, known as MSD outside the United States and Canada, has announced that Health Canada has granted approval of KEYTRUDA...

JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatment

Eli Lilly buys new injectable medicine manufacturing facility from Nexus Pharma

Ruchika Sharma23 April 2024 12:30 PM IST

Indianapolis: Eli Lilly and Company and Nexus Pharmaceuticals, LLC have announced a definitive agreement for Lilly to acquire a manufacturing...

Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France for USD 300 million

Sandoz confirms European Commission nod of Pyzchiva

Ruchika Sharma23 April 2024 11:54 AM IST

Basel: Sandoz has announced that the European Commission (EC) has granted marketing authorization for Pyzchiva (biosimilar ustekinumab) developed...

Zydus Lifesciences launches Mirabegron ER Tablets in US for overactive bladder treatment

Ruchika Sharma22 April 2024 2:47 PM IST

Mirabegron is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and urinary frequency.

Zydus Lifesciences arm gets marketing nod for Nulibry from UK MHRA for MoCD Type A

Ruchika Sharma22 April 2024 2:08 PM IST

Ahmedabad: Zydus Lifesciences Ltd. has announced that its wholly-owned subsidiary Sentynl Therapeutics, Inc., has received marketing...

Lupin receives positive EMA comittee opinion for eye therapy Ranluspec

Lupin unveils Mirabegron ER tablets in US

Ruchika Sharma22 April 2024 12:09 PM IST

Mumbai: Global pharma major Lupin Limited has announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the United States, after...

Merck unveils all-in-one genetic stability assay to accelerate biosafety testing

Ruchika Sharma21 April 2024 5:37 PM IST

Germany: Merck, a science and technology company, has launched the all-in-one, validated genetic stability assay of its kind. The Aptegra CHO...

CDSCO Panel Approves Updated Package Insert for Takedas Vedolizumab

Takeda gets USFDA nod for Entyvio subcutaneous administration for Crohn's disease

Ruchika Sharma21 April 2024 10:00 AM IST

Osaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO (vedolizumab) subcutaneous (SC)...

Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma

Roche Alecensa gets USFDA nod for ALK-positive early-stage lung cancer

Ruchika Sharma20 April 2024 12:05 PM IST

Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment following...

Shilpa Medicare bags initial authorization for Rotigotine Transdermal Patch from Europe

Shilpa Medicare marketing partner unveils Pemrydi Rtu in US

Ruchika Sharma20 April 2024 11:17 AM IST

PEMRYDI RTU is a novel ready-to-use injection which eliminates the need for refrigeration or reconstitution and dilution for administration to the...

Biocon Gets USFDA Approval for Everolimus Oral Suspension in Pediatric, Adult TSC

Biocon Limited signs an exclusive licensing and supply agreement for generic Ozempic (Semaglutide) commercialization in Brazil with Biomm S.A.

Ruchika Sharma20 April 2024 10:13 AM IST

Biocon, Biomm S.A. ink pact for diabetes drug Semaglutide commercialization in Brazil

Mac-Chem Products Boisar facility Successfully Renews EU GMP Certification

Ruchika Sharma19 April 2024 5:38 PM IST

Mumbai: Mac-Chem Products (India) Pvt. Ltd. (Mac-Chem) announced today the successful renewal of its European Union Goods Manufacturing...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok